Dr David Fyfe
Chief Executive Officer

Dr Jeremy Burroughes
Chief Technology Officer

Dr Scott Brown
Vice President, Research & Development and Commercial 

Emma Jones
Vice President, Human Resources & Facilities

Dr David Fyfe, a 30-year veteran of the global chemical and engineering industries, joined CDT as Chairman of the Board of Directors and Chief Executive Officer in September 2000.

He is experienced in driving commercial businesses and has extensive expertise in negotiating joint ventures, acquisitions and partnerships. Previous positions include senior executive roles in companies on both sides of the Atlantic, including ICI and BF Goodrich.

Dr Fyfe spent three years as CEO of Harris Speciality Chemicals (HSC), headquartered in Jacksonville, FL, USA. This $250 million turnover company had 900 employees, seven manufacturing plants in the U.S., and 11 locations in Europe and Asia. At HSC, Fyfe led a very successful turnaround and subsequent sale of the company to SKW - part of Germany's Viag Group - on behalf of Kelso & Company, one of the principal investors in CDT.

With a BA and MA from Cambridge University in Natural Sciences and a PhD for a dissertation in electrochemistry, Dr Fyfe has chaired and taken part in a number of industry focused government bodies. He has chaired the UK Chemical Industries Association Business and Trade Board, was a member of the UK Department of Trade and Industry's deregulation taskforce for the chemical and pharmaceutical industries and Vice Chairman of the UK CBI Northern Region.

After submitting his PhD thesis titled ‘The Physical Processes in Organic Semiconductor Polymer Devices’, Dr Burroughes discovered that conjugated polymers such as polyphenylene vinylene could show electroluminescence. A patent was filed by Dr Burroughes and his research fellows shortly afterwards.

With more than ten years’ research experience in conjugated polymer science and semiconductor technologies, Dr Burroughes joined CDT in 1997 to manage its new research group. After holding the position of Technical Director for two years he was promoted to Product Business Unit Director in 2000, and then CTO in November 2001. 

Previously, Dr Burroughes spent six years with Toshiba in the UK and Japan where he worked on quantum electronic and opto-electronic devices fabricated using GaAs or InP regrowth technology.

Dr Scott Brown joined CDT in May 2002. Previously he worked for Dow Corning Corporation, joining them in 1987 as a Research Scientist. During his early career, he gained broad experience, managing pan-European research and development teams. He is familiar with the challenges of a manufacturing environment, having spent two years at Dow Corning's largest manufacturing site in Carrollton, Kentucky. In 1999, Dr Brown moved to Midland, Michigan to take the position of Global Research & Development Director for Dow Corning's Electronics Business, managing teams in Europe and Japan, as well as the US.

Dr Brown has a BSc and PhD in Chemistry from the University of Exeter and an MBA from Oxford Brookes University.

Dr Brown is also Executive Vice President of Sumation, CDT's joint venture with Sumitomo Chemical.

Emma Jones is responsible for leading the Human Resources function as well as managing the facilities functions in the UK.

Prior to joining CDT, Ms Jones was head of Human Resources at Amgen Limited, where she was responsible for the management of the Human Resources function for the UK subsidiary of Amgen Inc, a US bio-pharmaceutical company. Ms Jones has a BA (Hons) degree in Business Studies from the University of Sheffield.